Drug Trial Radar · NCT06683742
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
400
Planned (sponsor's estimate)
Start
Nov 27, 2024
Primary completion
Sep 9, 2026
Study completion Mar 2027
Sponsor
- Lead sponsor
- EyePoint Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 12, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
Conditions
- Wet Age Related Macular Degeneration
- wAMD
Interventions
EYP-1901Drug
Intravitreal Injection
Aflibercept (2.0 mg)Drug
Intravitreal Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Average change in best corrected visual acuity (BCVA)Time frame: Weeks 52 and 56
Locations
113 sites in 10 countries. Site status is shown where the registry gives one.
Associated Retina Consultans
Gilbert, Arizona
Associated Retina Consultants - Phoenix
Phoenix, Arizona
Phoenix Retina Clinical Trials, LLC
Phoenix, Arizona
Retina Macula Institute of Arizona
Scottsdale, Arizona
Win Retina
Arcadia, California
Doctor Retina, PC
Beverly Hills, California
The Retina Partners
Encino, California
RCOC Clinical Research Institute Inc.
Fullerton, California
Global Research Management, Inc.
Glendale, California
Atlantis Eyecare
Huntington Beach, California
South Coast Retina Center
Long Beach, California
Retinal Consultants Medical Group
Modesto, California
Northern California Retina Vitreous Associates Medical Group INC.
Mountain View, California
Kaiser Permanente
Oakland, California
California Retina Consultants Oxnard Office
Oxnard, California
California Eye Specialists Medical Group, Inc.
Redlands, California
Retina Consultants of Southern California
Redlands, California
VRMG Inc
Sacramento, California
Bay Area Retina Associates
Walnut Creek, California
Retina Consultants of Southern Colorado
Colorado Springs, Colorado
RSC Research, PLLC
Denver, Colorado
Eye Center of Northern Colorado, PC
Fort Collins, Colorado
Colorado Retina Associates
Lakewood, Colorado
Connecticut Eye Consultants, P.C.
Danbury, Connecticut
SightSera Clinical Research LLC
Greenwich, Connecticut
Blue Ocean Clinical Research
Clearwater, Florida
Rand Eye Institute
Deerfield Beach, Florida
Retina Group of Florida
Fort Lauderdale, Florida
The Eye Institute of West Florida
Largo, Florida
Retina Care Specialists
Palm Beach Gardens, Florida
Fort Lauderdale Eye Institute
Plantation, Florida
MedEye Associates
South Miami, Florida
Retina Vitreous Associates of Florida - Saint Petersburg
St. Petersburg, Florida
East Florida Eye Institute
Stuart, Florida
Retina Specialists of Tampa
Tampa, Florida
Gailey Eye Clinic
Bloomington, Illinois
Retina Associates
Elmhurst, Illinois
Illinois Retina Associates, S.C.
Oak Park, Illinois
3RP/ Windy City Retina
Plainfield, Illinois
AVRUC
Carmel, Indiana
Showing 40 of 113 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.